NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

世界冠狀病毒疫苗管道分析

Global Coronavirus Vaccines Pipeline Report

出版商 IMAPAC PTE. LTD 商品編碼 941254
出版日期 內容資訊 英文 190 Pages
商品交期: 最快1-2個工作天內
價格
世界冠狀病毒疫苗管道分析 Global Coronavirus Vaccines Pipeline Report
出版日期: 2020年04月10日內容資訊: 英文 190 Pages
簡介

COVID-19疫苗的開發正以前所未有的速度進行,並且比典型的疫苗開發過程要快得多。這種快速步伐的部分原因可能是由於SARS/MERS先前所做的工作,目前已用於COVID-19。

本報告調查和分析了150多個致力於疫苗開發的組織,重點關注正在進行的COVID-19大流行和以前的SARS/MERS爆發,並按地區列出了當前可用疫苗的市場。它提供有關信息和管道分析的系統信息。

內容

第1章冠狀病毒疫苗管道的概述和分析

  • 冠狀病毒疫苗開發概述
  • 已開發疫苗類型
  • SARS-CoV-2疫苗候選藥物亮點(第一階段和第二階段)
  • 研發資金和投資
  • 已實現的發展里程碑概述
  • 發展階段和臨床試驗時間表分析(SARS-CoV-2疫苗)
  • 精選的SARS-CoV-2疫苗開發商
  • SWOT分析:SARS-CoV-2疫苗生產線

第2章SARS-CoV-2疫苗利益相關者

  • SARS-CoV-2疫苗開發概述
  • 合作重點
  • 在美洲開發SARS-CoV-2疫苗
  • 美洲SARS-CoV-2生物製藥公司
    • Altimmune
  • 公司概述
      • Applied DNA Sciences
      • Arcturus Therapeutics
      • Codagenix
      • Dynavax Technologies Corporation
      • Emergent BioSolutions
      • EpiVax
      • Flow Pharma
      • Generex Biotechnology
      • Geovax
      • Greffex
      • Heat Biologics
      • iBio Inc
      • Inovio Pharmaceuticals
      • Johnson & Johnson
      • Medicago
      • Moderna Therapeutics
      • Novavax
      • Pfizer
      • Tonix Pharmaceuticals
      • Vaxart
      • Vaxil Bio
    • 參與SARS-CoV-2疫苗開發的研究機構(美國)
      • Baylor College of Medicine
      • International AIDS Vaccine Initiative (IAVI)
      • Southern Research
      • University of Georgia
      • University of Miami
      • University of Pittsburgh, Erasmus
      • VIDO-InterVac, University of Saskatchewan
    • 採購基金:學術/研究機構(北美和南美)
    • 夥伴關係/合作:學術/研究機構(美洲)
    • 在歐洲,中東和非洲開發SARS-CoV-2疫苗
    • 歐洲,中東和非洲的SARS-CoV-2生物製藥公司
      • AdaptVac
      • AJ Vaccines
      • Batavia Biosciences
      • Biocad
      • BioNTech
      • CureVac
      • ExpreS2ion Biotechnologies
      • GlaxoSmithKline (GSK)
      • Sanofi Pasteur
      • Takis Biotechnology
      • Themis Bioscience GmbH
      • Valneva
    • 參與SARS-CoV-2疫苗開發的研究機構(歐洲/中東/非洲)
      • Centro Nacional Biotecnologia
      • MIGAL Galilee Research Institute
      • Imperial College London
      • Institute Pasteur
      • OncoGen
      • University of Cambridge
      • University of Oxford
    • 發展階段:學術/研究機構(歐洲/中東/非洲)
    • 採購基金:學術/研究機構(歐洲/中東/非洲)
    • 夥伴關係/合作:學術/研究機構(歐洲/中東/非洲)
    • 在亞太地區開發SARS-CoV-2疫苗
      • Adimmune Corporation
      • AnGes
      • Bharat Biotech
      • Biological E
      • BioNet-Asia
      • BravoVax
      • CanSino Biologics Inc
      • CC-Pharming
      • Clover Biopharmaceuticals
      • Daiichi-Sankyo
      • Fosun Pharma
      • G+FLAS Life Sciences
      • GC Pharma
      • Genexine
      • Hester Biosciences
      • Indian Immunologicals Limited
      • Medigen Vaccine Biologics Corporation
      • RNACure Biopharma
      • SaudiVax
      • Serum Institute of India
      • Sinovac Biotech
      • SK Bioscience
      • Sumagen
      • Xiamen Innovax Biotech
      • Zydus Cadila
    • 參與SARS-CoV-2疫苗開發的研究機構(亞太地區)
      • Beijing Advaccine Biotechnology Co.
      • Beijing Bio-Institute of Biological Products
      • Beijing Institute of Biotechnology
      • DUKE-NUS Medical School
      • Fudan University
      • IIT Guwahati
      • Institute of Biotechnology of the Academy Medical Sciences
      • Osaka University
      • Shanghai JiaoTong University
      • Shenzhen Geno-Immune Medical Institute
      • University of Hong Kong
      • University of Queensland
      • Wuhan Institute of Biological Products
    • 採購基金:學術/研究機構(亞太地區)
    • 採購基金:學術/研究機構(亞太地區)
    • 夥伴關係/合作:學術/研究機構(亞太)

    第3章SARS-CoV疫苗公司

    • SARS冠狀病毒疫苗開發概述
    • 參與SARS-CoV疫苗開發的生物製藥公司
      • Novavax
      • Sanofi Pasteur
      • Sinovac Biotech
      • Vaxine Pty Ltd
    • 參與SARS冠狀病毒疫苗研發的研究機構

    第4章MERS疫苗公司

    • MERS-CoV疫苗開發概述
    • 參與MERS-CoV疫苗開發的生物製藥公司
      • Geneone Life Science
      • Greffex
      • IDT Biologika Gmbh
      • Inovio Pharmaceuticals
      • Novavax
      • SK BIOSCIENCE
      • Themis Bioscience Gmbh
    • 參與MERS-CoV疫苗開發的研究機構

    第5章專家的觀點和分析

    • 行業考慮
    • 受訪者人口統計
    • 重點
    • 參考
    • 縮寫
目錄

COVID-19 vaccine development is proceeding at an unprecedented pace, achieving a substantially accelerated time frame in comparison to the typical vaccine development process. Part of this rapid pace can be attributed to the prior work done with SARS and MERS and now is being used for COVID-19.

‘The Global Coronavirus Vaccines Pipeline report’ features a comprehensive data analysis of over 150 organizations working on developing vaccines focused on the ongoing COVID-19 pandemic and the previous SARS and MERS outbreaks. It provides market intelligence and pipeline analysis on the current available vaccines region-wise, specifically from the Americas, Europe, the Middle East and Africa (EMEA), and the Asia-Pacific region (APAC). It captures detailed profiles of these companies, the ongoing partnerships as well as growth and financial performance analysis.

In addition, it pulls together insights from interviews and surveys with key opinion leaders who committed to developing an affordable vaccine for emergency pandemic use. The Global Coronavirus Vaccines Pipeline report seeks to holistically inform the community on the current status of coronavirus vaccine development and discover future opportunities for collaboration, technology transfer and co-development.

TABLE OF CONTENTS

SECTION 1: CORONAVIRUS VACCINES PIPELINE OVERVIEW & ANALYSIS

  • OVERVIEW OF CORONAVIRUS VACCINE DEVELOPMENT
  • TYPES OF VACCINES DEVELOPED
  • HIGHLIGHT OF SARS-COV-2 VACCINE CANDIDATES IN PHASE 1-2 TRIALS
  • R&D FUNDING & INVESTMENT
  • SUMMARY OF DEVELOPMENT MILETONES ACVHIEVED (JANUARY - APRIL 2020)
    • January 2020
    • Manufacturing Sites
    • Facility Design
  • STAGE OF DEVELOPMENT & CLINICAL TRIAL TIMELINE ANALYSIS - SARS-COV-2 VACCINES
  • SARS-COV-2 VACCINE DEVELOPERS TO WATCH OUT FOR
  • SWOT ANALYSIS: SARS-CoV2 VACCINE PIPELINE

SECTION 2: SARS-CoV-2 VACCINE STAKEHOLDERS

  • OVERVIEW OF SARS-COV-2 VACCINE DEVELOPMENT
  • PARTNERSHIP HIGHLIGHTS
  • SARS-COV-2-VACCINE DEVELOPMENT IN THE AMERICAS
  • SARS-COV-2 BIOPHARMA IN THE AMERICAS
    • Altimmune
  • COMPANY SNAPSHOTS
    • Applied DNA Sciences
    • Arcturus Therapeutics
    • Codagenix
    • Dynavax Technologies Corporation
    • Emergent BioSolutions
    • EpiVax
    • Flow Pharma
    • Generex Biotechnology
    • Geovax
    • Greffex
    • Heat Biologics
    • iBio Inc
    • Inovio Pharmaceuticals
    • Johnson & Johnson
    • Medicago
    • Moderna Therapeutics
    • Novavax
    • Pfizer
    • Tonix Pharmaceuticals
    • Vaxart
    • Vaxil Bio
  • RESEARCH INSTITUTES INVOLVED IN THE SARS-COV-2 VACCINES DEVELOPMENT (THE AMERICAS)
    • Baylor College of Medicine
    • International AIDS Vaccine Initiative (IAVI)
    • Southern Research
    • University of Georgia
    • University of Miami
    • University of Pittsburgh, Erasmus
    • VIDO-InterVac, University of Saskatchewan
  • FUNDING RECEIVED: ACADEMICS & RESEARCH INSTITUTES (THE AMERICAS)
  • PARTNERSHIPS & COLLABORATION: ACADEMICS & RESEARCH INSTITUTES (THE AMERICAS)
  • SARS-COV-2-VACCINE DEVELOPMENT IN EMEA
  • SARS-CoV-2 BIOPHARMA IN EMEA
    • AdaptVac
    • AJ Vaccines
    • Batavia Biosciences
    • Biocad
    • BioNTech
    • CureVac
    • ExpreS2ion Biotechnologies
    • GlaxoSmithKline (GSK)
    • Sanofi Pasteur
    • Takis Biotechnology
    • Themis Bioscience GmbH
    • Valneva
  • RESEARCH INSTITUTES INVOLVED IN THE SARS-CoV-2 VACCINES DEVELOPMENT (EMEA)
    • Centro Nacional Biotecnologia
    • MIGAL Galilee Research Institute
    • Imperial College London
    • Institute Pasteur
    • OncoGen
    • University of Cambridge
    • University of Oxford
  • PHASE OF DEVELOPMENT: ACADEMICS & RESEARCH INSTITUTES (EMEA)
  • FUNDING RECEIVED: ACADEMICS & RESEARCH INSTITUTES (EMEA)
  • PARTNERSHIPS & COLLABORATION: ACADEMICS & RESEARCH INSTITUTES (EMEA)
  • SARS-COV-2-VACCINE DEVELOPMENT IN APAC
    • Adimmune Corporation
    • AnGes
    • Bharat Biotech
    • Biological E
    • BioNet-Asia
    • BravoVax
    • CanSino Biologics Inc
    • CC-Pharming
    • Clover Biopharmaceuticals
    • Daiichi-Sankyo
    • Fosun Pharma
    • G+FLAS Life Sciences
    • GC Pharma
    • Genexine
    • Hester Biosciences
    • Indian Immunologicals Limited
    • Medigen Vaccine Biologics Corporation
    • RNACure Biopharma
    • SaudiVax
    • Serum Institute of India
    • Sinovac Biotech
    • SK Bioscience
    • Sumagen
    • Xiamen Innovax Biotech
    • Zydus Cadila
  • RESEARCH INSTITUTES INVOLVED IN THE SARS-COV-2 VACCINES DEVELOPMENT (APAC)
    • Beijing Advaccine Biotechnology Co.
    • Beijing Bio-Institute of Biological Products
    • Beijing Institute of Biotechnology
    • DUKE-NUS Medical School
    • Fudan University
    • IIT Guwahati
    • Institute of Biotechnology of the Academy Medical Sciences
    • Osaka University
    • Shanghai JiaoTong University
    • Shenzhen Geno-Immune Medical Institute
    • University of Hong Kong
    • University of Queensland
    • Wuhan Institute of Biological Products
  • FUNDING RECEIVED: ACADEMICS & RESEARCH INSTITUTES (APAC)
  • FUNDING RECEIVED: ACADEMICS & RESEARCH INSTITUTES (APAC)
  • PARTNERSHIPS & COLLABORATION: ACADEMICS & RESEARCH INSTITUTES (APAC)

SECTION 3: SARS-CoV VACCINE PLAYERS

  • OVERVIEW OF SARS-COV VACCINE DEVELOPMENT:
  • BIOPHARMA INVOLVED IN SARS-COV VACCINES DEVELOPMENT
    • Novavax
    • Sanofi Pasteur
    • Sinovac Biotech
    • Vaxine Pty Ltd
  • RESEARCH INSTITUTES INVOLVED IN SARS-COV VACCINE DEVELOPMENT

SECTION 4: MERS VACCINE PLAYERS

  • OVERVIEW OF MERS-COV VACCINE DEVELOPMENT:
  • BIOPHARMA INVOLVED IN -COV MERS VACCINE DEVELOPMENT
    • Geneone Life Science
    • Greffex
    • IDT Biologika Gmbh
    • Inovio Pharmaceuticals
    • Novavax
    • SK BIOSCIENCE
    • Themis Bioscience Gmbh
  • RESEARCH INSTITUTES INVOLVED IN MERS-COV VACCINE DEVELOPMENT

SECTION 5: EXPERTS OPINION POLL & ANALYSIS

  • Exclusive Industry Insights Captured
  • RESPONDENTS' DEMOGRAPHICS
  • KEY TAKEAWAYS
    • I) Realistic Timeline for the Vaccine to Enter Markets
    • II) Mutations of the SARS-CoV-2 Strain
    • III) Poll on the most promising Type of Vaccine for SARS-CoV-2
    • IV) Approach for SARS-CoV-2 vs. SARS
    • V) Factors Driving Collaborations for SARS-CoV-2 Vaccine Development
    • VI) Vaccine Community's Approach & Effort
    • VII) A few approaches to take to tackle the pandemic better
    • VIII) Perception of Medical Research after SARS-CoV-2 situation
    • XII) Noteworthy Countries and Companies in the SARS-CoV-2 Vaccine Development Spectrum Quoted by the Survey Respondents
  • IN-CONSERVATION WITH:
    • Medicago
    • BravoVax
    • Bharat Biotech
    • Novavax
    • Nugenerex Immuno-Oncology
    • Cansino Biologics
    • Moderna
    • IVI
    • Johnson & Johnson
    • Epivax
    • Inovio Pharmaceuticals
    • Geovax
    • Serum Institute of India
  • BIBLIOGRAPHY
  • ABBREVIATIONS